Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening

Amino Acids

Volumn 47, Issue 2, 2015, Pages 281-289

  Lee, Kyoung Jin ^a   Lee, Jae Hee ^a   Chung, Hye Kyung ^b   Choi, Jinhyang ^a   Park, Jaesook ^a   Park, Seok Soon ^a   Ju, Eun Jin ^a   Park, Jin ^a   Shin, Seol Hwa ^a   Park, Hye Ji ^a   Ko, Eun Jung ^a   Suh, Nayoung ^a   Kim, Inki ^a   Hwang, Jung Jin ^a   Song, Si Yeol ^a   Jeong, Seong Yun ^a   Choi, Eun Kyung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Human lung cancer; In vivo screening; Peptide; Phage display

Indexed keywords

PEPTIDE; PEPTIDE G1; PEPTIDE G10; PEPTIDE G11; PEPTIDE G12; PEPTIDE G13; PEPTIDE G14; PEPTIDE G15; PEPTIDE G16; PEPTIDE G17; PEPTIDE G18; PEPTIDE G19; PEPTIDE G2; PEPTIDE G20; PEPTIDE G3; PEPTIDE G4; PEPTIDE G5; PEPTIDE G6; PEPTIDE G7; PEPTIDE G8; PEPTIDE G9; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PEPTIDE LIBRARY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BIOPANNING; CONTROLLED STUDY; ENTEROBACTERIA PHAGE M13; HEART; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; LUNG; LUNG CANCER; LUNG CANCER CELL LINE; MOLECULAR CLONING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SEQUENCE HOMOLOGY; SPLEEN; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; LUNG NEOPLASMS; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PEPTIDE LIBRARY; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84922004246     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1852-6     Document Type: Article

References (29)

1. Azzazy HM, Highsmith WE Jr (2002) Phage display technology: clinical applications and recent innovations. Clin Biochem 35:425-445
2. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 104:15549-15554. doi: 10.1073/pnas.0707461104
3. Carrico ZM et al (2012) N-Terminal labeling of filamentous phage to create cancer marker imaging agents. ACS nano 6:6675-6680. doi: 10.1021/nn301134z
4. Choi J et al (2012) Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials 33:4195-4203. doi: 10.1016/j.biomaterials.2012.02.022
5. Collins LG, Haines C, Perkel R, Enck RE (2007) Lung cancer: diagnosis and management. Am Fam Physician 75:56-63
6. Conraux L et al (2013) Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling. PloS One 8:e79733. doi: 10.1371/journal.pone.0079733
7. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML (2006) The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 121:144-158. doi: 10.1016/j.clim.2006.06.010
8. de Bruin EC et al (2014) Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer. Cancer Discov. doi: 10.1158/2159-8290.CD-13-0741
9. Du B et al (2006) In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem Biophys Res Commun 342:956-962
10. Fei L, Yap LP, Conti PS, Shen WC, Zaro JL (2014) Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. Biomaterials. doi: 10.1016/j.biomaterials.2014.01.047
11. Garanger E, Boturyn D, Dumy P (2007) Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers. Anticancer Agents Med Chem 7:552-558
12. Ghosh D, Lee Y, Thomas S, Kohli AG, Yun DS, Belcher AM, Kelly KA (2012) M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat Nanotechnol 7:677-682. doi: 10.1038/nnano.2012.146
13. Guckenberger M et al (2012) Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer? J Thorac 7:542-551. doi: 10.1097/JTO.0b013e31824165d7
14. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90. doi: 10.3322/caac.20107
15. Ko JH, Gu W, Lim I, Bang H, Ko EA, Zhou T (2014) Ion channel gene expression in lung adenocarcinoma: potential role in prognosis and diagnosis. PloS One 9:1. doi: 10.1371/journal.pone.0086569
16. Larimer BM, Thomas WD, Smith GP, Deutscher SL (2014) Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display. Mol Imaging Biol 16(4):449-458. doi: 10.1007/s11307-014-0724-5
17. Liu C, Wen Z, Li Y, Peng L (2014) Application of ThinPrep bronchial brushing cytology in the early diagnosis of lung cancer: a retrospective study. PloS One 9:e90163. doi: 10.1371/journal.pone.0090163
18. Molek P, Strukelj B, Bratkovic T (2011) Peptide phage display as a tool for drug discovery: targeting membrane receptors. Molecules 16:857-887. doi: 10.3390/molecules16010857
19. Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S (2012) Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 82:1149-1156. doi: 10.1016/j.ijrobp.2011.03.005
20. Park HY, Kim J, Cho JH, Moon JY, Lee SJ, Yoon MY (2011) Phage display screen for peptides that bind Bcl-2 protein. J Biomol Screen 16:82-89. doi: 10.1177/1087057110385816
21. Ploss M et al (2014) Selection of peptides binding to metallic borides by screening M13 phage display libraries. BMC Biotechnol 14:12. doi: 10.1186/1472-6750-14-12
22. Qi Q, Lu N, Li C, Zhao J, Liu W, You Q, Guo Q (2014) Involvement of RECK in gambogic acid induced anti-invasive effect in A549 human lung carcinoma cells. Molecular Carcinog doi: 10.1002/mc.22138
23. Schumacher TN, Tsomides TJ (2001) In vitro radiolabeling of peptides and proteins. Curr Protoc Protein Sci Chapter 3: Unit 3.3 doi: 10.1002/0471140864.ps0303s00
24. Sidhu SS (2001) Engineering M13 for phage display. Biomol Eng 18:57-63
25. Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317
26. Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B (2013) A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS nano 7:2935-2947. doi: 10.1021/nn305663e
27. Vincent RG et al (1977) The changing histopathology of lung cancer: a review of 1682 cases. Cancer 39:1647-1655
28. Wu X, Chen H, Wang X (2012) Can lung cancer stem cells be targeted for therapies? Cancer Treat Rev 38:580-588. doi: 10.1016/j.ctrv.2012.02.013
29. Zhu W et al (2014) Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One 9:e87780. doi: 10.1371/journal.pone.0087780